Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib. (Q53048127)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib. |
scientific article |
Statements
Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib. (English)
Atsushi Hiraoka
Masashi Hirooka
Yohei Koizumi
Hirofumi Izumoto
Hidetaro Ueki
Miho Kaneto
Shogo Kitahata
Toshihiko Aibiki
Hideomi Tomida
Yuji Miyamoto
Hiroka Yamago
Yoshifumi Suga
Ryuichiro Iwasaki
Kenichiro Mori
Hideki Miyata
Eiji Tsubouchi
Masato Kishida
Tomoyuki Ninomiya
Masanori Abe
Bunzo Matsuura
Hideki Kawasaki
Yoichi Hiasa
Kojiro Michitaka
30 August 2016
47
6
558-565